Petra Bistrovic

Zagreb, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use.

Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use.

Journal: Journal of psychopharmacology (Oxford, England)

Published: March 14, 2024

Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients.

Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients.

Journal: Expert opinion on pharmacotherapy

Published: February 16, 2024

Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients.

Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients.

Journal: Viruses

Published: November 30, 2023

Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities.

Negative Prognostic Associations of Selective Serotonin Reuptake Inhibitors Use in Hospitalized COVID-19 Patients and Potential Contribution of Cardiovascular Comorbidities.

Journal: Pharmacology

Published: September 20, 2023

Relative Bradycardia and Tachycardia and Their Associations with Adverse Outcomes in Hospitalized COVID-19 Patients.

Relative Bradycardia and Tachycardia and Their Associations with Adverse Outcomes in Hospitalized COVID-19 Patients.

Journal: Reviews in cardiovascular medicine

Published: April 04, 2023

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events.

Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events.

Journal: The American journal of emergency medicine

Published: March 05, 2023

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry.

Journal: Croatian medical journal

Published: January 04, 2023

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients - A retrospective cohort study on 5392 patients from a tertiary centre.

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients - A retrospective cohort study on 5392 patients from a tertiary centre.

Journal: International journal of cardiology

Published: November 16, 2022

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis.

Journal: The American journal of emergency medicine

Published: April 26, 2022

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.

Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.

Journal: The Journal of infection

Published: April 23, 2022

Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients.

Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients.

Journal: Journal of medical virology

Published: March 21, 2022

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients.

Remdesivir-associated bradycardia might be a sign of good prognosis in COVID-19 patients.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: December 11, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026